...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients.
【24h】

Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients.

机译:健康人,癌症和癌症易感综合症患者细胞体外照射后的染色体畸变个体差异。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Radiosensitivity of normal tissue is a crucial factor of radiotherapy (RT)-related side effects. Here, we report the analysis of spontaneous and in vitro irradiation-induced chromosomal aberrations in 256,679 metaphases from 222 different individuals using three-color fluorescence in situ hybridization as a measure of radiosensitivity. MATERIALS AND METHODS: Samples were categorized into the following 6 groups: (1) healthy individuals, (2) cancer patients prior to radiotherapy, (3) RT-treated cancer patients, (4) individuals heterozygous or (5) homozygous for a mutation in the ataxia telangiectasia mutated (ATM) gene or in the Nijmegen breakage syndrome (NBS1) gene and (6) hypersensitive patients (outliers). RESULTS: A normal distribution of the number of chromosomal aberrations, measured as breaks per metaphase (B/m), was adopted for all examined groups. The mean value of the control group was 0.40B/m (SD+/-0.07). This value was lower compared to the mean breakage rate from 175 non-exposed(0.50+/-0.12B/m) and pre-exposed (0.50+/-0.16B/m) cancer patients. Nineteen of the metaphase spreads from the analyzed cancer patients had a high number of chromosomal aberrations (1.04+/-0.29B/m) and were designated as a separate hypersensitive subgroup (outliers). The aberration frequency of this group was comparable to those of ATM or NBS1 heterozygotes (0.86+/-0.26B/m). The highest incidence of aberrations was observed in ATM and NBS1 homozygous patients (2.23+/-1.03B/m). CONCLUSION: The frequency of break events in the analyzed groups resulted in a normal distribution with varying means and broadnesses defining a characteristic sensitivity pattern for each group. In the RT-relevant group of cancer patients, those patients who have cancer, about one-third of the normally distributed samples were determined to be sensitive as defined by the number of induced aberrations higher than the 99% confidence interval of the normal individual's Gaussian distribution. About 5% of these samples were outside of the 99% confidence interval for the RT-relevant group's normal distribution. These outliers with higher chromosomal breakage rates suggest a unique class of hypersensitive individuals that are susceptible to chromosomal damage and may be directly associated with an increased risk to suffer from radiotherapy-related complications.
机译:背景:正常组织的放射敏感性是与放射治疗(RT)相关的副作用的关键因素。在这里,我们报告使用三色荧光原位杂交作为放射敏感性的量度,对来自222个不同个体的256,679个中期的自发和体外照射诱导的染色体畸变进行了分析。材料与方法:样品分为以下6组:(1)健康个体,(2)放疗前的癌症患者,(3)RT治疗的癌症患者,(4)杂合子或(5)突变纯合子共济失调毛细血管扩张突变(ATM)基因或奈梅亨破坏综合症(NBS1)基因中的过敏症和(6)过敏症患者(异常值)。结果:所有检查组均采用染色体畸变数的正态分布,以每个中期的断裂数(B / m)表示。对照组的平均值为0.40B / m(SD +/- 0.07)。与175名未暴露(0.50 +/- 0.12B / m)和预暴露(0.50 +/- 0.16B / m)癌症患者的平均破损率相比,该值更低。来自分析过的癌症患者的十九个中期扩散具有大量的染色体畸变(1.04 +/- 0.29B / m),并被指定为一个单独的超敏亚组(异常值)。该组的像差频率与ATM或NBS1杂合子的像差频率相当(0.86 +/- 0.26B / m)。在ATM和NBS1纯合患者中,畸变发生率最高(2.23 +/- 1.03B / m)。结论:分析组中断裂事件的发生频率导致正态分布,均值和宽度各异,为每组定义了特征敏感性模式。在与RT相关的癌症患者组中,那些患有癌症的患者中,大约三分之一的正态分布样本被确定为敏感的,这是由高于正常个体的高斯99%置信区间的诱发像差​​定义分配。这些样本中约有5%位于RT相关组的正态分布的99%置信区间之外。这些具有较高染色体破损率的异常值表明,一类独特的超敏个体易受染色体损伤,并可能直接增加与放射治疗相关并发症的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号